Reserpine for the Treatment of Cocaine Dependence - 1

Completed · Phase 2

Conditions studied: Cocaine-Related Disorders, Substance-Related Disorders

In brief

The purpose of this study is to assess the efficacy and safety of reserpine for the treatment of cocaine dependence.

Key facts

Study ID

NCT00033033

Run by

National Institute on Drug Abuse (NIDA)

People needed

140

Starts

2001-07-01

Expected to finish

2003-05-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be at least 18 yrs of age; DSM-4 diagnosis of cocaine dependence; treatment seeking individuals; have the ability to understand and provide written informed consent; females of child bearing potential using appropriate birth control method

You may not qualify if…

• Additional criteria available during screening at the site.

Where it is running

• Boston University Medical Center — Boston, Massachusetts, United States
• Cincinnati VA Medical Center — Cincinnati, Ohio, United States
• Dayton VA Medical Center — Dayton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.